Joshua Gagne, PharmD, ScD, FISPE

Vice President and Global Head of Epidemiology
Johnson & Johnson

Poster(s):

• (A-184) Potential for Extreme Bias Due to Outcome Misclassification in Relative Measures of Effect for Rare Time-to-Event Outcomes
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET